4Filed Aug 2, 8:00 PM ET
Apnimed (APMD) Director Lawrence G. Miller Converts/Reclassifies ~3.13M Shares
$APMD · Apnimed, Inc.Research Summary
AI-generated summary of this SEC filing
Apnimed (APMD) Director Lawrence G. Miller Converts/Reclassifies ~3.13M Shares
What Happened
- Lawrence G. Miller, a director of Apnimed, reported a large set of transactions on August 3, 2026 consisting primarily of reclassifications and conversions of derivative securities into common stock. The filing shows paired "disposition to the issuer" and "grant/award or other acquisition" entries, plus a few conversions of derivative securities, many recorded at $0.00.
- Aggregating the entries, about 3,130,797 shares were involved (total acquired ≈ 3,130,797; total disposed ≈ 3,130,797). No cash consideration is reported for the derivative conversions (entries at $0.00), indicating internal conversions/reclassifications rather than open-market buys or cash sales.
Key Details
- Transaction date: August 3, 2026.
- Aggregate shares affected: ~3,130,797 (acquired and disposed; net change appears to be zero based on paired entries).
- Reported prices/consideration: mostly N/A or $0.00 (derivative conversions / reclassifications).
- Notable footnotes:
- F1: Class A Common Stock was reclassified into one share of Common Stock under Rule 16b-7/16b-3.
- F3: Series A Preferred automatically converted one-for-one into Class A Common prior to the IPO.
- F2: Reporting person disclaims beneficial ownership except to the extent of any pecuniary interest.
- Other footnotes (F4–F8) describe vesting schedules for various options/awards referenced in the filing.
- Filing timeliness: Reported with a period of Aug 3, 2026; the filing does not indicate a late report.
Context
- These entries appear to reflect internal corporate reclassifications and conversions (e.g., preferred or derivative securities converted to common shares) and not open-market purchases or cash sales. Derivative transactions recorded at $0.00 generally mean conversion or net settlement rather than a paid purchase.
- Because the reporting person disclaims beneficial ownership per the footnote, this filing should be read with that disclaimer in mind; it may reflect technical / corporate bookkeeping actions rather than a change in an insider’s economic position.